Tuesday, June 24, 2008

FDA Update, 6/24/2008

New and Generic Drug Approvals

cetirizine hydrochloride syrup, (active ingredient in Zyrtec)Taro Pharmaceutical Industries, Ltd., Approval
Durezol (difluprednate) Ophthalmic Emulsion (first ophthalmic steroid indicated for inflammation and pain ), Sirion Therapeutics, Inc., Approval
ramipril Capsules, (Altace) (for hypertension)Dr. Reddy's Labs, Ltd., Approval
Ramipril Capsules, Apotex Corp., Approval
valganciclovir hydrochloride tablets, (Valcyte) (CMV retinitis) Ranbaxy, Inc., Tentative Approval
Zaleplon capsules, (sonata) (insomnia treatment)Cipla, Ltd., Approval

No comments: